BTCS (BTCS) 10-Q11 Aug 232023 Q2 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	6 Months Ended
Cover - shares	Jun. 30, 2023	Aug. 09, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2023
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	001-40792
Entity Registrant Name	BTCS Inc.
Entity Central Index Key	0001436229
Entity Tax Identification Number	90-1096644
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	9466 Georgia Avenue #124
Entity Address, City or Town	Silver Spring
Entity Address, State or Province	MD
Entity Address, Postal Zip Code	20910
City Area Code	202
Local Phone Number	430-6576
Title of 12(b) Security	Common Stock, par value $0.001
Trading Symbol	BTCS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		14,333,292

Balance Sheets

Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash	$ 943,418	$ 2,146,783
Crypto assets/currencies	948	982
Investments, at value (Cost $100,000)	100,000	100,000
Staked crypto assets/currencies	8,185,089	1,826,307
Prepaid expense	175,395	123,727
Total current assets	9,404,850	4,197,799
Other assets:
Property and equipment, net	8,834	11,152
Staked crypto assets/currencies - long term		5,708,624
Total other assets	8,834	5,719,776
Total Assets	9,413,684	9,917,575
Liabilities and Stockholders’ Equity:
Accounts payable and accrued expense	188,144	76,727
Accrued compensation	253,995	295,935
Warrant liabilities	356,250	213,750
Total current liabilities	798,389	586,412
Stockholders’ equity:
Series V Preferred stock: 14,542,803 and 0 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively
Common stock, 97,500,000 shares authorized at $0.001 par value, 14,181,410 and 13,107,149 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	14,182	13,108
Additional paid in capital	159,955,610	160,800,263
Accumulated deficit	(153,914,030)	(151,482,208)
Total stockholders’ equity	8,615,295	9,331,163
Total Liabilities and Stockholders’ Equity	9,413,684	9,917,575
Series V Preferred Stock [Member]
Stockholders’ equity:
Series V Preferred stock: 14,542,803 and 0 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	$ 2,559,533

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, par value	$ 0.001	$ 0.001
Common stock, shares authorised	97,500,000	97,500,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	14,181,410	13,107,149
Common stock, shares outstanding	14,181,410	13,107,149
Series V Preferred Stock [Member]
Preferred Stock, Shares Outstanding	14,542,803	0

Statements of Operations (Unaud

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
Statements of Operations (Unaudited) - USD ($)	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenues
Validator revenue (net of fees)	$ 385,753	$ 514,349	$ 697,261	$ 1,077,364
Total revenues	385,753	514,349	697,261	1,077,364
Cost of revenues
Validator expense	113,612	93,900	195,626	231,769
Gross profit	272,141	420,449	501,635	845,595
Operating expenses:
General and administrative	617,569	512,051	1,227,398	1,162,340
Research and development	180,903	185,004	382,528	321,722
Compensation and related expenses	578,496	638,025	1,040,586	2,061,921
Marketing	2,723	23,691	8,966	65,484
Impairment loss on crypto assets/currencies	784,602	8,894,797	879,509	12,202,225
Realized gains on crypto asset/currency transactions	(731,199)	(398,446)	(748,030)	(469,556)
Total operating expenses	1,433,094	9,855,122	2,790,957	15,344,136
Other income (expenses):
Change in fair value of warrant liabilities	142,500	1,710,000	(142,500)	1,068,750
Distributions to warrant holders				(35,625)
Total other income (expenses)	142,500	1,710,000	(142,500)	1,033,125
Net loss	$ (1,018,453)	$ (7,724,673)	$ (2,431,822)	$ (13,465,416)
Net loss per share attributable to common stockholders, basic	$ (0.07)	$ (0.61)	$ (0.18)	$ (1.08)
Net loss per share attributable to common stockholders, diluted	$ (0.07)	$ (0.61)	$ (0.18)	$ (1.08)
Weighted average number of common shares outstanding, basic	13,873,331	12,644,719	13,773,782	12,446,102
Weighted average number of common shares outstanding, diluted	13,873,331	12,644,719	13,773,782	12,446,102

Statements of Changes in Stockh

Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock [Member] Series V Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2021		$ 10,529	$ 147,682,384	$ (135,589,470)	$ 12,103,443
Balance, shares at Dec. 31, 2021		10,528,212
Issuance of common stock, net of offering cost / At-the-market offering		$ 1,831	10,602,610		10,604,441
Issuance of common stock, net of offering cost / At-the-market offering, shares		1,830,588
Stock-based compensation		$ 345	1,782,457		1,782,802
Stock-based compensation, shares		344,994
Net loss				(13,465,416)	(13,465,416)
Dividend distributions			(634,557)		(634,557)
Ending balance, value at Jun. 30, 2022		$ 12,705	159,432,894	(149,054,886)	10,390,713
Balance, shares at Jun. 30, 2022		12,703,794
Beginning balance, value at Mar. 31, 2022		$ 12,617	158,848,780	(141,330,213)	17,531,184
Balance, shares at Mar. 31, 2022		12,616,010
Issuance of common stock, net of offering cost / At-the-market offering		$ 40	90,634		90,674
Issuance of common stock, net of offering cost / At-the-market offering, shares		40,012
Stock-based compensation		$ 48	493,480		493,528
Stock-based compensation, shares		47,772
Net loss				(7,724,673)	(7,724,673)
Dividend distributions
Ending balance, value at Jun. 30, 2022		$ 12,705	159,432,894	(149,054,886)	10,390,713
Balance, shares at Jun. 30, 2022		12,703,794
Beginning balance, value at Dec. 31, 2022		$ 13,108	160,800,263	(151,482,208)	9,331,163
Balance, shares at Dec. 31, 2022		13,107,149
Issuance of common stock, net of offering cost / At-the-market offering		$ 651	925,850		926,501
Issuance of common stock, net of offering cost / At-the-market offering, shares		651,172
Issuance of Series V preferred stock	$ 2,559,533		(2,559,533)
Issuanceof Series V preferred stock, shares	14,542,803
Stock-based compensation		$ 423	789,030		789,453
Stock-based compensation, shares		423,089
Net loss				(2,431,822)	(2,431,822)
Ending balance, value at Jun. 30, 2023	$ 2,559,533	$ 14,182	159,955,610	(153,914,030)	8,615,295
Balance, shares at Jun. 30, 2023	14,542,803	14,181,410
Beginning balance, value at Mar. 31, 2023		$ 13,800	161,839,971	(152,895,577)	8,958,194
Balance, shares at Mar. 31, 2023		13,799,745
Issuance of common stock, net of offering cost / At-the-market offering		$ 350	417,369		417,719
Issuance of common stock, net of offering cost / At-the-market offering, shares		350,018
Issuance of Series V preferred stock	$ 2,559,533		(2,559,533)
Issuanceof Series V preferred stock, shares	14,542,803
Stock-based compensation		$ 32	257,803		257,835
Stock-based compensation, shares		31,647
Net loss				(1,018,453)	(1,018,453)
Ending balance, value at Jun. 30, 2023	$ 2,559,533	$ 14,182	$ 159,955,610	$ (153,914,030)	$ 8,615,295
Balance, shares at Jun. 30, 2023	14,542,803	14,181,410

Statements of Cash Flows (Unaud

Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Net Cash flows used from operating activities:
Net loss	$ (2,431,822)	$ (13,465,416)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	2,318	1,727
Stock-based compensation	789,453	1,782,802
Validator revenue	(697,261)	(1,077,364)
Blockchain network fees (non-cash)		1,321
Change in fair value of warrant liabilities	142,500	(1,068,750)
Sale of non-productive crypto assets/currencies		2,547,322
Realized gain on crypto assets/currencies transactions	(748,030)	(469,556)
Impairment loss on crypto assets/currencies	879,509	12,202,225
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(51,668)	63,376
Accounts payable and accrued expenses	111,417	565
Accrued compensation	(41,940)	132,853
Net cash used in operating activities	(2,045,524)	651,105
Net cash used in investing activities:
Purchase of productive crypto assets/currencies for validating	(1,804,213)	(9,141,785)
Sale of productive crypto assets/currencies	1,719,871	310,149
Purchase of investments
Purchase of property and equipment		(2,558)
Net cash used in investing activities	(84,342)	(8,834,194)
Net cash provided by financing activities:
Dividend distributions		(630,801)
Net proceeds from issuance common stock/ At-the-market offering	926,501	10,604,441
Net cash provided by financing activities	926,501	9,973,640
Net increase in cash	(1,203,365)	1,790,551
Cash, beginning of period	2,146,783	1,400,867
Cash, end of period	943,418	3,191,418
Supplemental disclosure of non-cash financing and investing activities:
Series V Preferred Stock Distribution	$ 2,559,533

Business Organization and Natur

Business Organization and Nature of Operations	6 Months Ended
Business Organization and Nature of Operations	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business Organization and Nature of Operations	Note 1 - Business Organization and Nature of Operations BTCS Inc. (formerly Bitcoin Shop, Inc.), a Nevada corporation (“BTCS” or the “Company”) was incorporated in 2008 and is an early entrant in the crypto asset (also referred to “cryptocurrencies”, “crypto”, or “tokens”) market with a primary focus on blockchain infrastructure and staking. The Company operates validator nodes on various proof-of-stake (“PoS”) and delegated proof-of-stake (“DPoS”) based blockchain networks and stakes the native crypto assets on those blockchains to earn rewards. The Company’s Staking-as-a-Service (“StaaS”) business allows crypto asset holders to earn rewards by participating in network consensus mechanisms through staking and delegating their crypto assets to Company-operated validator nodes (or “nodes”). The Company believes that StaaS provides a more accessible and cost-effective way for crypto asset holders to participate in blockchain networks’ consensus mechanisms, thereby promoting the growth and adoption of blockchain technology. The Company’s recently launched StakeSeeker platform (the “Digital Asset Platform”), currently in beta, is a comprehensive crypto dashboard and education center designed to empower users to better understand and grow their crypto holdings with innovative portfolio analytics and a non-custodial process to earn staking rewards through direct participation in blockchain consensus algorithms. The Company’s business is subject to various risks and uncertainties, including risks associated with the evolving regulatory landscape for crypto assets, risks associated with the volatility of crypto asset prices, and risks associated with the development and adoption of blockchain technology. The Company’s future success is dependent on various factors, including the growth of the crypto asset market, the adoption of blockchain technology, and the Company’s ability to effectively operate and grow its blockchain infrastructure operations and StaaS business. The Company plans to expand its PoS operations to secure other disruptive blockchain protocols that also allow for delegating and asset leveraging. The growth of both StakeSeeker’s user base as well as the number and size of staked cryptocurrencies by delegators to Company-run validator nodes are critical to the Company’s strategy and success.

Basis of Presentation

Basis of Presentation	6 Months Ended
Basis of Presentation	Jun. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Note 2 - Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information, the instructions to Form 10-Q and the rules and regulations of the SEC. Accordingly, since they are interim statements, the accompanying unaudited condensed financial statements do not include all of the information and notes required by GAAP for annual financial statements, but in the opinion of the Company’s management, reflect all adjustments consisting of normal, recurring adjustments, that are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. Interim results for the three and six months ended June 30, 2023 are not necessarily indicative of results for the full year ended December 31, 2023. The unaudited condensed financial statements and notes should be read in conjunction with the financial statements and notes for the year ended December 31, 2022.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
Summary of Significant Accounting Policies	Jun. 30, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 3 - Summary of Significant Accounting Policies There have been no material changes in the Company’s significant accounting policies to those previously disclosed in the 2022 Annual Report. Basis of presentation The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”). Reclassifications Certain prior period amounts have been reclassified in order to conform with the current period presentation. These reclassifications have no impact on the Company’s previously reported net income (loss). Concentration of Cash The Company maintains cash balances at three financial institutions in checking accounts and money market accounts. The Company considers all highly liquid investments with original maturities of six months or less when purchased to be cash and cash equivalents. As of June 30, 2023 and December 31, 2022, the Company had approximately $ 0.9 2.1 Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $ 250,000 0.3 1.7 Revenue Recognition The Company recognizes revenue under Accounting Standards Codification (“ASC”) 606 , Revenue from Contracts with Customers ● Step 1: Identify the contract with the customer ● Step 2: Identify the performance obligations in the contract ● Step 3: Determine the transaction price ● Step 4: Allocate the transaction price to the performance obligations in the contract ● Step 5: Recognize revenue when the Company satisfies a performance obligation Revenue is recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company generates revenue through staking rewards. The Company has entered into network-based smart contracts by running its own crypto asset validator nodes as well as by staking crypto assets on nodes run by third-party operators (either directly or through crypto exchanges). Through these contracts, the Company provides cryptocurrency to stake on a node for the purpose of validating transactions and adding blocks to a respective blockchain network. The term of a smart contract can vary based on the rules of the respective blockchain and typically last a few weeks to months after it is cancelled by the operator and requires that the cryptocurrency staked remain locked up during the duration of the smart contract. In exchange for staking the cryptocurrency and validating transactions on blockchain networks, the Company is entitled to all of the fixed cryptocurrency award for running the Company’s own node and is entitled to a fractional share of the fixed cryptocurrency award a third-party node operator receives (less crypto asset transaction fees payable to the node operator or exchanges, which are immaterial and are recorded as a deduction from revenue), for successfully validating or adding a block to the blockchain. The Company’s fractional share of awards received from delegating to a third-party validator node is based on the proportion of cryptocurrency the Company staked to the node to the total cryptocurrency staked by delegators to the node. The provision of validating blockchain transactions is an output of the Company’s ordinary activities. Each separate block creation or validation under a smart contract with a network represents a performance obligation. The transaction consideration the Company receives - the cryptocurrency award - is a non-cash consideration, which the Company measures at fair value on the date received. The fair value of the cryptocurrency award received is determined using the quoted price of the related cryptocurrency on the date of receipt. The satisfaction of the performance obligation for processing and validating blockchain transactions occurs at a point in time when confirmation is received from the network indicating that the validation is complete, and the awards are available for transfer. At that point, revenue is recognized. Cost of Revenue The Company’s cost of revenue consists primarily of direct production costs related to the operations of validating transactions on the network, rent and utilities for locations housing server nodes to the extent applicable, hosting costs if cloud-based servers are utilized and fees (including equity compensation stock-based fees) paid to 3rd parties to assist in software maintenance and operations of its nodes. Crypto Assets Translations and Remeasurements The Company accounts for its crypto assets as indefinite-lived intangible assets in accordance with ASC 350, Intangibles – Goodwill and Other Crypto assets held are included in the balance sheets as either current assets or other assets if they are staked and locked up for over one year. The Company’s crypto assets are initially recorded at fair value upon receipt (or “carrying value”). The fair value of crypto assets is determined using the U.S. dollar spot price of the related crypto asset. On a quarterly basis, crypto assets are measured at carrying value, net of any impairment losses incurred since receipt. The Company will record impairment losses as the fair value falls below the carrying value of the crypto assets at any time during the period, as determined using the lowest U.S. dollar spot price of the related crypto asset subsequent to its acquisition. The crypto assets can only be marked down when impaired and not marked up when their value increases. Such impairment in the value of crypto assets is recorded as a component of costs and expenses in our Statements of Operations. The Company recorded impairment losses related to crypto assets of approximately $ 0.9 12.2 Impairment losses cannot be recovered for any subsequent increase in fair value until the sale or disposal of the asset. Realized gain (loss) on sale of crypto assets are included in other income (expense) in the Statements of Operations. The Company recorded realized gains (losses) on crypto assets of approximately $ 0.7 0.5 The presentation of purchases and sales of crypto assets on the Statement of Cash Flows is determined by the nature of the crypto assets, which can be characterized as productive (i.e. purchased for purposes of staking) or non-productive. The purchase of non-productive crypto assets and currencies are included as an operating activity, whereas the purchase of productive crypto assets and currencies are included as investing activities in accordance with ASC 230-10-20 Investing activities. Internally Developed Software Internally developed software consists of the core technology of the Company’s Digital Asset Platform, which is being designed to allow users to track, monitor and analyze their aggregate cryptocurrency portfolio holdings by connecting their crypto exchanges and digital wallets as well as providing a non-custodial delegation process to earn staking rewards on crypto asset holdings. For internally developed software, the Company uses both its own employees as well as the services of external vendors and independent contractors. The Company accounts for computer software used in the business in accordance with ASC 985-20 and ASC 350. ASC 985-20, Software-Costs of Computer Software to Be Sold, Leased, or Otherwise Marketed, ASC 350, Intangibles-Goodwill and Other Property and Equipment Property and equipment consists of computer, equipment and office furniture and fixtures, all of which are recorded at cost. Depreciation and amortization are recorded using the straight-line method over the respective useful lives of the assets ranging from three five years Use of Estimates The accompanying financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include the recoverability and useful lives of indefinite life intangible assets, stock-based compensation, and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates, including the carrying amount of the indefinite life intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions. Income Taxes The Company recognizes income taxes on an accrual basis based on tax positions taken or expected to be taken in its tax returns. A tax position is defined as a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities. Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement Accounting for Warrants The Company accounts for the issuance of Common Stock purchase warrants issued in connection with the equity offerings in accordance with the provisions of ASC 815, Derivatives and Hedging (“ASC 815”). The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net-cash settle the contract if an event occurs and if that event is outside the control of the Company) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). In addition, Under ASC 815, registered Common Stock warrants that require the issuance of registered shares upon exercise and do not expressly preclude an implied right to cash settlement are accounted for as derivative liabilities. The Company classifies these derivative warrant liabilities on the balance sheet as a current liability. The Company assessed the classification of Common Stock purchase warrants as of the date of each offering and determined that such instruments originally met the criteria for equity classification; however, as a result of the Company no longer being in control of whether the warrants may be cash settled, the instruments no longer qualify for equity classification. Accordingly, the Company classified the warrants as a liability at their fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until the warrants are exercised or expired, and any change in fair value is recognized as “change in the fair value of warrant liabilities” in the statements of operations. The fair value of the warrants has been estimated using a Black-Scholes valuation model (see Note 4). Stock-based compensation The Company accounts for stock-based compensation in accordance with ASC 718 Compensation – Stock Compensation (“ASC 718”). ASC 718 addresses all forms of share-based payment awards including shares issued under employee stock purchase plans and stock incentive shares. Under ASC 718 awards result in a cost that is measured at fair value on the awards’ grant date, based on the estimated number of awards that are expected to vest and will result in a charge to operations. Share-based payment awards exchanged for services are accounted for at the fair value of the award on the estimated grant date. Options Stock options issued under the Company’s long-term incentive plans are granted with an exercise price equal to no less than the market price of the Company’s stock at the date of grant and expire up to ten years from the date of grant. These options often vest over a one-year period. The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. Restricted Stock Units (RSUs) For awards vesting upon the achievement of a service condition, compensation cost measured on the grant date will be recognized on a straight-line basis over the vesting period. Stock-based compensation expense for the market-based restricted stock units with explicit service conditions is recognized on a straight-line basis over the longer of the derived service period or the explicit service period, regardless of whether the market condition is satisfied. However, in the event that the explicit service period is not met, previously recognized compensation cost would be reversed. Market-based restricted stock units subject to market-based performance targets require achievement of the performance target as well as a service condition in order for these RSUs to vest. The Company estimates the fair value of market-based RSUs as of the grant date and expected derived term using a Monte Carlo simulation that incorporates pricing inputs covering the period from the grant date through the end of the derived service period. Dividends Effective January 27, 2023, the Company’s Board of Directors (the “Board”) approved the issuance of a newly designated Series V Preferred Stock (“Series V”) on a one-for-one basis to the Company’s shareholders (including restricted stock unit holders and warrant holders who were entitled to such distribution). The distribution of Series V shares was approved and completed on June 2, 2023 to shareholders as of the record date of May 12, 2023. The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board) . A total of 14,542,803 shares of Series V Preferred Stock were distributed to shareholders on June 2, 2023. On January 5, 2022, the Board declared a non-recurring special dividend of $ 0.05 0 635,000 The Company will evaluate the appropriateness of potential future dividends as the Company continues to grow its operations. Advertising Expense Advertisement costs are expensed as incurred and included in marketing expenses. Advertising and marketing expenses amounted to approximately $ 9,000 65,000 Net Loss per Share Basic loss per share is computed by dividing the net income or loss applicable to common shares by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the Company’s convertible preferred stock, convertible notes, restricted stock units, options and warrants. Diluted loss per share excludes the shares issuable upon the conversion of preferred stock, notes and warrants from the calculation of net loss per share if their effect would be anti-dilutive. The following financial instruments were not included in the diluted loss per share calculation as of June 30, 2023 and 2022 because their effect was anti-dilutive: Schedule of Earnings Per Share Anti-diluted 2023 2022 As of June 30, 2023 2022 Warrants to purchase common stock 712,500 945,837 Options 1,135,000 1,235,000 Non-vested restricted stock awards units 1,631,399 1,644,198 Total 3,478,899 3,825,035 Recent Accounting Pronouncements In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

Fair Value of Financial Assets

Fair Value of Financial Assets and Liabilities	6 Months Ended
Fair Value of Financial Assets and Liabilities	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value of Financial Assets and Liabilities	Note 4 – Fair Value of Financial Assets and Liabilities The Company measures certain assets and liabilities at fair value. The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 – Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 – Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability. Financial instruments, including cash and cash equivalents, accounts and other receivables, accounts payable and accrued liabilities are carried at cost, which management believes approximates fair value due to the short-term nature of these instruments. The following tables present the Company’s assets and liabilities that are measured at fair value on a recurring basis and the Company’s estimated level within the fair value hierarchy of those assets and liabilities as of June 30, 2023 and December 31, 2022: Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis Fair Value Measured at June 30, 2023 Quoted Significant prices in other Significant Total at active observable unobservable June 30, markets inputs inputs 2023 (Level 1) (Level 2) (Level 3) Assets Investments $ 100,000 $ - $ - $ 100,000 Liabilities Warrant Liabilities $ 356,250 $ - $ - $ 356,250 Fair Value Measured at December 31, 2022 Quoted Significant prices in other Significant Total at active observable unobservable December 31, markets inputs inputs 2022 (Level 1) (Level 2) (Level 3) Assets Investments $ 100,000 $ - $ - $ 100,000 Liabilities Warrant Liabilities $ 213,750 $ - $ - $ 213,750 The Company did not make any transfers between the levels of the fair value hierarchy during the six months ended June 30, 2023 and 2022. Level 3 Valuation Techniques Level 3 financial assets consist of private equity investments for which there is no current public market for these securities such that the determination of fair value requires significant judgment or estimation. As of June 30, 2023 and December 31, 2022, the Company’s Level 3 investments were carried at original cost of the investments, with a value of $ 100,000 Investments—Equity Securities Level 3 financial liabilities consist of the warrant liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. A significant decrease in the volatility or a significant decrease in the Company’s stock price, in isolation, would result in a significantly lower fair value measurement. Changes in the values of the warrant liabilities are recorded in “change in fair value of warrant liabilities” in the Company’s statements of operations. On March 2, 2021, the Company entered into a securities purchase agreement with certain purchasers which closed on March 4, 2021 pursuant to which the Company sold an aggregate of (i) 950,000 712,500 9.5 The Warrants require, at the option of the holder, a net-cash settlement following certain fundamental transactions (as defined in the Warrants) at the Company. At the time of issuance, the Company maintained control of certain fundamental transactions and as such the Warrants were initially classified in equity. As of December 31, 2022, the Company no longer maintained control of certain fundamental transactions as they did not control a majority of shareholder votes. As such, the Company may be required to cash settle the Warrants if a fundamental transaction occurs which is outside the Company’s control. Accordingly, the Warrants are classified as liabilities. The Warrants have been recorded at their fair value using the Black-Scholes valuation model, and will be recorded at their respective fair value at each subsequent balance sheet date. This model incorporates transaction details such as the Company’s stock price, contractual terms, maturity, risk-free rates, as well as volatility. The Warrants require the issuance of registered shares upon exercise, do not expressly preclude an implied right to cash settlement and are therefore accounted for as derivative liabilities. The Company classifies these derivative warrant liabilities on the balance sheet as a current liability. A summary of quantitative information with respect to the valuation methodology and significant unobservable inputs used for the Company’s warrant liabilities that are categorized within Level 3 of the fair value hierarchy at the date of issuance and, as of June 30, 2023 and December 31, 2022, is as follows: Summary of Valuation Methodology and Significant Unobservable Inputs Warrant Liabilities June 30, December 31, Risk-free rate of interest 4.49 % 3.99 % Expected volatility 144.6 % 152.8 % Expected life (in years) 2.68 3.18 Expected dividend yield - - The risk-free interest rate was based on rates established by the Federal Reserve Bank. For the Warrants, the Company estimates expected volatility giving primary consideration to the historical volatility of its Common Stock. The general expected volatility is based on the standard deviation of the Company’s underlying stock price’s daily logarithmic returns. The expected life of the warrants was determined by the expiration date of the warrants. The expected dividend yield was based on the fact that the Company has not historically paid dividends on its Common Stock and does not expect to pay recurring dividends on its Common Stock in the future. The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial assets and liabilities for the six months ended June 30, 2023 and 2022, that are measured at fair value on a recurring basis: Schedule of Changes in Fair Value and Other Adjustments of Warrants Fair Value of Level 3 Financial Assets June 30, June 30, 2023 2022 Beginning balance $ 100,000 $ - Purchases - - Unrealized appreciation (depreciation) - - Ending balance $ 100,000 $ - Fair Value of Level 3 Financial Liabilities June 30, June 30, 2023 2022 Beginning balance $ 213,750 $ 1,852,500 Warrant liabilities classification - - Fair value adjustment of warrant liabilities 142,500 (1,068,750 ) Ending balance $ 356,250 $ 783,750

Stockholders_ Equity

Stockholders’ Equity	6 Months Ended
Stockholders’ Equity	Jun. 30, 2023
Equity [Abstract]
Stockholders’ Equity	Note 5 – Stockholders’ Equity Common Stock The Company received shareholder approval on July 11, 2023 to amend our Articles of Incorporation to increase the number of authorized shares of common stock from 97,500,000 975,000,000 975,000,000 At The Market Offering Agreement On September 14, 2021, the Company entered into an At-The-Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC, as agent (“H.C. Wainwright”), pursuant to which the Company may offer and sell, from time-to-time through H.C. Wainwright, shares of the Company’s Common Stock having an aggregate offering price of up to $ 98,767,500 3.0% During the six months ended June 30, 2023, the Company sold a total of 651,172 965,000 1.48 927,000 Share Based Payments Effective January 19, 2023, The Board of Directors of the Company approved the issuance of $ 50,000 12,500 st 59,223 Preferred Stock Series V Effective January 27, 2023, the Board approved the issuance of a newly designated Series V Preferred Stock (“Series V”) on a one-for-one basis to the Company’s shareholders (including restricted stock unit holders and warrant holders). The distribution of Series V shares was approved and completed on June 2, 2023 to shareholders as of the record date of May 12, 2023. The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board of Directors) 14,542,803 The fair value of the Preferred stock as of the record date, May 12, 2023, amounted to $ 2.6 2021 Equity Incentive Plan The Company’s 2021 Equity Incentive Plan (the “2021 Plan”) was effective on January 1, 2021 and approved by shareholders on March 31, 2021 and amended on June 13, 2022. The Company received shareholder approval on July 11, 2023 to increase the authorized amount under the 2021 Plan from 7,000,000 12,000,000 Options During the six months ended June 30, 2023, the Company granted 20,000 0.63 The following weighted-average assumptions were used to estimate the fair value of options granted on the deemed grant date during the six months ended June 30, 2023 and 2022 for both the Black-Scholes formula: Schedule of Weighted-Average Assumptions Used to Estimate Fair Value Three Months Ended March 31, 2023 2022 Exercise price $ 0.63 - Term (years) 5.00 - Expected stock price volatility 152.8 % - Risk-free rate of interest 3.99 % - Expected Volatility Risk-Free Interest Rate Expected Term For awards vesting upon the achievement of the market conditions which were met at the date of grant, compensation cost measured on the date of grant was immediately recognized. For awards vesting upon the achievement of the market conditions which were not met at the date of grant, compensation cost measured on the grant date will be recognized on a straight-line basis over the vesting period based on estimation using a Monte-Carlo simulation. A summary of option activity under the Company’s stock option plan for six months ended June 30, 2023 is presented below: Summary of Option Activity Weighted Average Weighted Remaining Number of Average Total Contractual Life Shares Exercise Price Intrinsic Value (in years) Outstanding as of December 31, 2022 1,150,000 $ 2.15 $ - 3.3 Employee options granted 20,000 0.63 - - Employee options forfeited (35,000 ) 1.02 11,100 - Outstanding as of June 30, 2023 1,135,000 $ 2.16 $ - 2.8 Options vested and exercisable as of June 30, 2023 1,135,000 $ 2.16 $ - 2.8 RSUs Effective January 2, 2022, the Board of Directors of the Company ratified the following arrangements approved by its Compensation Committee: The Company’s executive officers were granted RSUs as part of a long-term incentive plan (“LTI”), with vesting terms set for when the Company’s market capitalization reaches and sustains a market capitalization for 30 consecutive days above four defined market capitalization thresholds of $ 100 150 200 400 Effective February 22, 2022, upon appointment of Manish Paranjape as Chief Technology Officer of the Company, Mr. Paranjape was also granted RSUs as part of the LTI plan, with consistent vesting terms set for when the Company’s market capitalization above the same four defined market capitalization thresholds. Effective January 1, 2023 (the “LTI RSU Amendment Date”), upon recommendation of the Compensation Committee of the Board of Directors approved an amendment to the LTI plan, whereby the market capitalization threshold targets were lowered to $ 50 100 150 300 The RSUs granted to each executive employee are as follows: Schedule of Restricted Stock Units Total Market Cap Vesting Thresholds Officer Name Title Grant Date RSUs Granted $ 50 million $ 100 million $ 150 million $ 300 million Charles Allen Chief Executive Officer 1/2/2022 694,444 173,611 173,611 173,611 173,611 Michal Handerhan Chief Operations Officer 1/2/2022 444,444 111,111 111,111 111,111 111,111 Michael Prevoznik Chief Financial Officer 1/2/2022 222,224 55,556 55,556 55,556 55,556 Manish Paranjape Chief Technology Officer 2/22/2022 160,184 40,046 40,046 40,046 40,046 1,521,296 380,324 380,324 380,324 380,324 To the extent any market capitalization targets set forth above for Mr. Prevoznik and Mr. Paranjape are achieved, the RSUs will also be subject to the following five-year vesting schedule: 20% 80% For awards vesting upon the achievement of a service condition, compensation cost measured on the grant date will be recognized on a straight-line basis over the vesting period. Stock-based compensation expense for the market-based restricted stock units with explicit service conditions is recognized on a straight-line basis over the longer of the derived service period or the explicit service period, regardless of whether the market condition is satisfied. However, in the event that the explicit service period is not met, previously recognized compensation cost would be reversed. Market-based restricted stock units subject to market-based performance targets require achievement of the performance target as well as a service condition in order for these RSUs to vest. The Company estimates the fair value of market-based RSUs as of the grant date and expected derived term using a Monte Carlo simulation that incorporates pricing inputs covering the period from the grant date through the end of the derived service period. As of the LTI RSU Amendment Date, the Company determined the pre-modification and post-modification estimated fair value of the LTI RSUs accounting for the amended market cap criteria. The increase in fair value of the LTI RSUs attributable to the modification was added to the related unrecognized compensation expense in accordance with ASC 718 – Share-Based Compensation The following weighted-average assumptions were used to estimate the fair value of options granted during the six months ended June 30, 2023 and 2022 for the Monte-Carlo simulation: Schedule of Weighted-Average Assumptions Used to Estimate Fair Value Valuation Dates January 1, 2023 January 2, 2022 (Modification) (Original Issuance) Vesting Hurdle Price $ 3.81 30.52 $ 8.07 36.99 Term (years) 4.00 5.00 Expected stock price volatility 97.30 % 103.72 % Risk-free rate of interest 4.10 % 1.32 % Expected Volatility Risk-Free Interest Rate Expected Term five five Vesting Hurdle Price: On December 9, 2022, upon recommendation of the Compensation Committee, the Board of Directors approved the grant of 25,000 A summary of the Company’s restricted stock units granted under the 2021 Plan during the six months ended June 30, 2023 are as follows: Summary of Restricted Stock Number of Weighted Average Restricted Grant Day Stock Units Fair Value Nonvested at December 31, 2022 1,590,552 $ 3.34 Granted 50,000 0.63 Vested (9,153 ) 4.37 Forfeited - - Nonvested at June 30, 2023 1,631,399 $ 3.25 Stock Based Compensation Stock-based compensation expense is recorded as a part of selling, general and administrative expenses, compensation expenses and cost of revenues. Stock-based compensation expense for the three and six months ended June 30, 2023 and 2022 was as follows: Schedule of Stock-based Compensation Expense 2023 2022 2023 2022 For the Three Months Ended June 30, For the Six Months Ended June 30, 2023 2022 2023 2022 Employee bonus stock awards $ - $ - $ - $ 894,027 Employee stock option awards (8,619 ) 12,812 (5,312 ) 82,446 Employee restricted stock unit awards 228,953 405,714 496,291 747,704 Non-employee restricted stock awards 8,333 89,656 24,242 171,737 Stock-based compensation $ 228,667 $ 508,182 $ 515,221 $ 1,895,914

Accrued Expenses

Accrued Expenses	6 Months Ended
Accrued Expenses	Jun. 30, 2023
Payables and Accruals [Abstract]
Accrued Expenses	Note 6 – Accrued Expenses Accrued expenses consist of the following: Schedule of Accrued Expenses June 30, 2023 December 31, 2022 Compensation and related expenses $ 253,995 $ 295,935 Accounts Payable 188,144 76,727 Accrued Expenses $ 442,139 $ 372,662 Accrued compensation and related expenses include approximately $ 254,000 284,000

Employee Benefit Plans

Employee Benefit Plans	6 Months Ended
Employee Benefit Plans	Jun. 30, 2023
Retirement Benefits [Abstract]
Employee Benefit Plans	Note 7 – Employee Benefit Plans The Company maintains defined contribution benefit plans under Section 401(k) of the Internal Revenue Code covering substantially all qualified employees of the Company (the “401(k) Plan”). Under the 401(k) Plan, the Company may make discretionary contributions of up to 100% 95,000 45,000

Liquidity

Liquidity	6 Months Ended
Liquidity	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Liquidity	Note 8 – Liquidity The Company follows “ Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern As reflected in the financial statements, the Company has historically incurred a net loss and has an accumulated deficit at June 30, 2023, a net loss and net cash used in operating activities for the reporting period then ended. The Company is implementing its business plan and generating revenue; however, the Company’s cash position and liquid crypto assets are sufficient to support its daily operations over the next twelve months.

Subsequent Events

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 9 – Subsequent Events The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements other than disclosed. During the period from July 1, 2023 to August 9, 2023, the Company sold a total of 151,882 shares of Common Stock under the ATM Agreement for aggregate total gross proceeds of approximately $ 195,000 at an average selling price of $ 1.28 per share, resulting in net proceeds of approximately $ 187,000 after deducting commissions and other transaction costs. On July 11, 2023, the Company filed an Amendment to the Articles of Incorporation with the Nevada Secretary of State increasing the authorized shares of common stock to 975

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
Summary of Significant Accounting Policies (Policies)	Jun. 30, 2023
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”).
Reclassifications	Reclassifications Certain prior period amounts have been reclassified in order to conform with the current period presentation. These reclassifications have no impact on the Company’s previously reported net income (loss).
Concentration of Cash	Concentration of Cash The Company maintains cash balances at three financial institutions in checking accounts and money market accounts. The Company considers all highly liquid investments with original maturities of six months or less when purchased to be cash and cash equivalents. As of June 30, 2023 and December 31, 2022, the Company had approximately $ 0.9 2.1 Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $ 250,000 0.3 1.7
Revenue Recognition	Revenue Recognition The Company recognizes revenue under Accounting Standards Codification (“ASC”) 606 , Revenue from Contracts with Customers ● Step 1: Identify the contract with the customer ● Step 2: Identify the performance obligations in the contract ● Step 3: Determine the transaction price ● Step 4: Allocate the transaction price to the performance obligations in the contract ● Step 5: Recognize revenue when the Company satisfies a performance obligation Revenue is recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company generates revenue through staking rewards. The Company has entered into network-based smart contracts by running its own crypto asset validator nodes as well as by staking crypto assets on nodes run by third-party operators (either directly or through crypto exchanges). Through these contracts, the Company provides cryptocurrency to stake on a node for the purpose of validating transactions and adding blocks to a respective blockchain network. The term of a smart contract can vary based on the rules of the respective blockchain and typically last a few weeks to months after it is cancelled by the operator and requires that the cryptocurrency staked remain locked up during the duration of the smart contract. In exchange for staking the cryptocurrency and validating transactions on blockchain networks, the Company is entitled to all of the fixed cryptocurrency award for running the Company’s own node and is entitled to a fractional share of the fixed cryptocurrency award a third-party node operator receives (less crypto asset transaction fees payable to the node operator or exchanges, which are immaterial and are recorded as a deduction from revenue), for successfully validating or adding a block to the blockchain. The Company’s fractional share of awards received from delegating to a third-party validator node is based on the proportion of cryptocurrency the Company staked to the node to the total cryptocurrency staked by delegators to the node. The provision of validating blockchain transactions is an output of the Company’s ordinary activities. Each separate block creation or validation under a smart contract with a network represents a performance obligation. The transaction consideration the Company receives - the cryptocurrency award - is a non-cash consideration, which the Company measures at fair value on the date received. The fair value of the cryptocurrency award received is determined using the quoted price of the related cryptocurrency on the date of receipt. The satisfaction of the performance obligation for processing and validating blockchain transactions occurs at a point in time when confirmation is received from the network indicating that the validation is complete, and the awards are available for transfer. At that point, revenue is recognized.
Cost of Revenue	Cost of Revenue The Company’s cost of revenue consists primarily of direct production costs related to the operations of validating transactions on the network, rent and utilities for locations housing server nodes to the extent applicable, hosting costs if cloud-based servers are utilized and fees (including equity compensation stock-based fees) paid to 3rd parties to assist in software maintenance and operations of its nodes.
Crypto Assets Translations and Remeasurements	Crypto Assets Translations and Remeasurements The Company accounts for its crypto assets as indefinite-lived intangible assets in accordance with ASC 350, Intangibles – Goodwill and Other Crypto assets held are included in the balance sheets as either current assets or other assets if they are staked and locked up for over one year. The Company’s crypto assets are initially recorded at fair value upon receipt (or “carrying value”). The fair value of crypto assets is determined using the U.S. dollar spot price of the related crypto asset. On a quarterly basis, crypto assets are measured at carrying value, net of any impairment losses incurred since receipt. The Company will record impairment losses as the fair value falls below the carrying value of the crypto assets at any time during the period, as determined using the lowest U.S. dollar spot price of the related crypto asset subsequent to its acquisition. The crypto assets can only be marked down when impaired and not marked up when their value increases. Such impairment in the value of crypto assets is recorded as a component of costs and expenses in our Statements of Operations. The Company recorded impairment losses related to crypto assets of approximately $ 0.9 12.2 Impairment losses cannot be recovered for any subsequent increase in fair value until the sale or disposal of the asset. Realized gain (loss) on sale of crypto assets are included in other income (expense) in the Statements of Operations. The Company recorded realized gains (losses) on crypto assets of approximately $ 0.7 0.5 The presentation of purchases and sales of crypto assets on the Statement of Cash Flows is determined by the nature of the crypto assets, which can be characterized as productive (i.e. purchased for purposes of staking) or non-productive. The purchase of non-productive crypto assets and currencies are included as an operating activity, whereas the purchase of productive crypto assets and currencies are included as investing activities in accordance with ASC 230-10-20 Investing activities.
Internally Developed Software	Internally Developed Software Internally developed software consists of the core technology of the Company’s Digital Asset Platform, which is being designed to allow users to track, monitor and analyze their aggregate cryptocurrency portfolio holdings by connecting their crypto exchanges and digital wallets as well as providing a non-custodial delegation process to earn staking rewards on crypto asset holdings. For internally developed software, the Company uses both its own employees as well as the services of external vendors and independent contractors. The Company accounts for computer software used in the business in accordance with ASC 985-20 and ASC 350. ASC 985-20, Software-Costs of Computer Software to Be Sold, Leased, or Otherwise Marketed, ASC 350, Intangibles-Goodwill and Other
Property and Equipment	Property and Equipment Property and equipment consists of computer, equipment and office furniture and fixtures, all of which are recorded at cost. Depreciation and amortization are recorded using the straight-line method over the respective useful lives of the assets ranging from three five years
Use of Estimates	Use of Estimates The accompanying financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include the recoverability and useful lives of indefinite life intangible assets, stock-based compensation, and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates, including the carrying amount of the indefinite life intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.
Income Taxes	Income Taxes The Company recognizes income taxes on an accrual basis based on tax positions taken or expected to be taken in its tax returns. A tax position is defined as a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities. Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement
Accounting for Warrants	Accounting for Warrants The Company accounts for the issuance of Common Stock purchase warrants issued in connection with the equity offerings in accordance with the provisions of ASC 815, Derivatives and Hedging (“ASC 815”). The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net-cash settle the contract if an event occurs and if that event is outside the control of the Company) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). In addition, Under ASC 815, registered Common Stock warrants that require the issuance of registered shares upon exercise and do not expressly preclude an implied right to cash settlement are accounted for as derivative liabilities. The Company classifies these derivative warrant liabilities on the balance sheet as a current liability. The Company assessed the classification of Common Stock purchase warrants as of the date of each offering and determined that such instruments originally met the criteria for equity classification; however, as a result of the Company no longer being in control of whether the warrants may be cash settled, the instruments no longer qualify for equity classification. Accordingly, the Company classified the warrants as a liability at their fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until the warrants are exercised or expired, and any change in fair value is recognized as “change in the fair value of warrant liabilities” in the statements of operations. The fair value of the warrants has been estimated using a Black-Scholes valuation model (see Note 4).
Stock-based compensation	Stock-based compensation The Company accounts for stock-based compensation in accordance with ASC 718 Compensation – Stock Compensation (“ASC 718”). ASC 718 addresses all forms of share-based payment awards including shares issued under employee stock purchase plans and stock incentive shares. Under ASC 718 awards result in a cost that is measured at fair value on the awards’ grant date, based on the estimated number of awards that are expected to vest and will result in a charge to operations. Share-based payment awards exchanged for services are accounted for at the fair value of the award on the estimated grant date. Options Stock options issued under the Company’s long-term incentive plans are granted with an exercise price equal to no less than the market price of the Company’s stock at the date of grant and expire up to ten years from the date of grant. These options often vest over a one-year period. The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. Restricted Stock Units (RSUs) For awards vesting upon the achievement of a service condition, compensation cost measured on the grant date will be recognized on a straight-line basis over the vesting period. Stock-based compensation expense for the market-based restricted stock units with explicit service conditions is recognized on a straight-line basis over the longer of the derived service period or the explicit service period, regardless of whether the market condition is satisfied. However, in the event that the explicit service period is not met, previously recognized compensation cost would be reversed. Market-based restricted stock units subject to market-based performance targets require achievement of the performance target as well as a service condition in order for these RSUs to vest. The Company estimates the fair value of market-based RSUs as of the grant date and expected derived term using a Monte Carlo simulation that incorporates pricing inputs covering the period from the grant date through the end of the derived service period.
Dividends	Dividends Effective January 27, 2023, the Company’s Board of Directors (the “Board”) approved the issuance of a newly designated Series V Preferred Stock (“Series V”) on a one-for-one basis to the Company’s shareholders (including restricted stock unit holders and warrant holders who were entitled to such distribution). The distribution of Series V shares was approved and completed on June 2, 2023 to shareholders as of the record date of May 12, 2023. The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board) . A total of 14,542,803 shares of Series V Preferred Stock were distributed to shareholders on June 2, 2023. On January 5, 2022, the Board declared a non-recurring special dividend of $ 0.05 0 635,000 The Company will evaluate the appropriateness of potential future dividends as the Company continues to grow its operations.
Advertising Expense	Advertising Expense Advertisement costs are expensed as incurred and included in marketing expenses. Advertising and marketing expenses amounted to approximately $ 9,000 65,000
Net Loss per Share	Net Loss per Share Basic loss per share is computed by dividing the net income or loss applicable to common shares by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the Company’s convertible preferred stock, convertible notes, restricted stock units, options and warrants. Diluted loss per share excludes the shares issuable upon the conversion of preferred stock, notes and warrants from the calculation of net loss per share if their effect would be anti-dilutive. The following financial instruments were not included in the diluted loss per share calculation as of June 30, 2023 and 2022 because their effect was anti-dilutive: Schedule of Earnings Per Share Anti-diluted 2023 2022 As of June 30, 2023 2022 Warrants to purchase common stock 712,500 945,837 Options 1,135,000 1,235,000 Non-vested restricted stock awards units 1,631,399 1,644,198 Total 3,478,899 3,825,035
Recent Accounting Pronouncements	Recent Accounting Pronouncements In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
Summary of Significant Accounting Policies (Tables)	Jun. 30, 2023
Accounting Policies [Abstract]
Schedule of Earnings Per Share Anti-diluted	The following financial instruments were not included in the diluted loss per share calculation as of June 30, 2023 and 2022 because their effect was anti-dilutive: Schedule of Earnings Per Share Anti-diluted 2023 2022 As of June 30, 2023 2022 Warrants to purchase common stock 712,500 945,837 Options 1,135,000 1,235,000 Non-vested restricted stock awards units 1,631,399 1,644,198 Total 3,478,899 3,825,035

Fair Value of Financial Asset_2

Fair Value of Financial Assets and Liabilities (Tables)	6 Months Ended
Fair Value of Financial Assets and Liabilities (Tables)	Jun. 30, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis	The following tables present the Company’s assets and liabilities that are measured at fair value on a recurring basis and the Company’s estimated level within the fair value hierarchy of those assets and liabilities as of June 30, 2023 and December 31, 2022: Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis Fair Value Measured at June 30, 2023 Quoted Significant prices in other Significant Total at active observable unobservable June 30, markets inputs inputs 2023 (Level 1) (Level 2) (Level 3) Assets Investments $ 100,000 $ - $ - $ 100,000 Liabilities Warrant Liabilities $ 356,250 $ - $ - $ 356,250 Fair Value Measured at December 31, 2022 Quoted Significant prices in other Significant Total at active observable unobservable December 31, markets inputs inputs 2022 (Level 1) (Level 2) (Level 3) Assets Investments $ 100,000 $ - $ - $ 100,000 Liabilities Warrant Liabilities $ 213,750 $ - $ - $ 213,750
Summary of Valuation Methodology and Significant Unobservable Inputs Warrant Liabilities	A summary of quantitative information with respect to the valuation methodology and significant unobservable inputs used for the Company’s warrant liabilities that are categorized within Level 3 of the fair value hierarchy at the date of issuance and, as of June 30, 2023 and December 31, 2022, is as follows: Summary of Valuation Methodology and Significant Unobservable Inputs Warrant Liabilities June 30, December 31, Risk-free rate of interest 4.49 % 3.99 % Expected volatility 144.6 % 152.8 % Expected life (in years) 2.68 3.18 Expected dividend yield - -
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Schedule of Changes in Fair Value and Other Adjustments of Warrants	The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial assets and liabilities for the six months ended June 30, 2023 and 2022, that are measured at fair value on a recurring basis: Schedule of Changes in Fair Value and Other Adjustments of Warrants Fair Value of Level 3 Financial Assets June 30, June 30, 2023 2022 Beginning balance $ 100,000 $ - Purchases - - Unrealized appreciation (depreciation) - - Ending balance $ 100,000 $ - Fair Value of Level 3 Financial Liabilities June 30, June 30, 2023 2022 Beginning balance $ 213,750 $ 1,852,500 Warrant liabilities classification - - Fair value adjustment of warrant liabilities 142,500 (1,068,750 ) Ending balance $ 356,250 $ 783,750

Stockholders_ Equity (Tables)

Stockholders’ Equity (Tables)	6 Months Ended
Stockholders’ Equity (Tables)	Jun. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value	The following weighted-average assumptions were used to estimate the fair value of options granted during the six months ended June 30, 2023 and 2022 for the Monte-Carlo simulation: Schedule of Weighted-Average Assumptions Used to Estimate Fair Value Valuation Dates January 1, 2023 January 2, 2022 (Modification) (Original Issuance) Vesting Hurdle Price $ 3.81 30.52 $ 8.07 36.99 Term (years) 4.00 5.00 Expected stock price volatility 97.30 % 103.72 % Risk-free rate of interest 4.10 % 1.32 %
Summary of Option Activity	A summary of option activity under the Company’s stock option plan for six months ended June 30, 2023 is presented below: Summary of Option Activity Weighted Average Weighted Remaining Number of Average Total Contractual Life Shares Exercise Price Intrinsic Value (in years) Outstanding as of December 31, 2022 1,150,000 $ 2.15 $ - 3.3 Employee options granted 20,000 0.63 - - Employee options forfeited (35,000 ) 1.02 11,100 - Outstanding as of June 30, 2023 1,135,000 $ 2.16 $ - 2.8 Options vested and exercisable as of June 30, 2023 1,135,000 $ 2.16 $ - 2.8
Schedule of Restricted Stock Units	The RSUs granted to each executive employee are as follows: Schedule of Restricted Stock Units Total Market Cap Vesting Thresholds Officer Name Title Grant Date RSUs Granted $ 50 million $ 100 million $ 150 million $ 300 million Charles Allen Chief Executive Officer 1/2/2022 694,444 173,611 173,611 173,611 173,611 Michal Handerhan Chief Operations Officer 1/2/2022 444,444 111,111 111,111 111,111 111,111 Michael Prevoznik Chief Financial Officer 1/2/2022 222,224 55,556 55,556 55,556 55,556 Manish Paranjape Chief Technology Officer 2/22/2022 160,184 40,046 40,046 40,046 40,046 1,521,296 380,324 380,324 380,324 380,324
Summary of Restricted Stock	A summary of the Company’s restricted stock units granted under the 2021 Plan during the six months ended June 30, 2023 are as follows: Summary of Restricted Stock Number of Weighted Average Restricted Grant Day Stock Units Fair Value Nonvested at December 31, 2022 1,590,552 $ 3.34 Granted 50,000 0.63 Vested (9,153 ) 4.37 Forfeited - - Nonvested at June 30, 2023 1,631,399 $ 3.25
Schedule of Stock-based Compensation Expense	Stock-based compensation expense is recorded as a part of selling, general and administrative expenses, compensation expenses and cost of revenues. Stock-based compensation expense for the three and six months ended June 30, 2023 and 2022 was as follows: Schedule of Stock-based Compensation Expense 2023 2022 2023 2022 For the Three Months Ended June 30, For the Six Months Ended June 30, 2023 2022 2023 2022 Employee bonus stock awards $ - $ - $ - $ 894,027 Employee stock option awards (8,619 ) 12,812 (5,312 ) 82,446 Employee restricted stock unit awards 228,953 405,714 496,291 747,704 Non-employee restricted stock awards 8,333 89,656 24,242 171,737 Stock-based compensation $ 228,667 $ 508,182 $ 515,221 $ 1,895,914
2021 Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value	Schedule of Weighted-Average Assumptions Used to Estimate Fair Value Three Months Ended March 31, 2023 2022 Exercise price $ 0.63 - Term (years) 5.00 - Expected stock price volatility 152.8 % - Risk-free rate of interest 3.99 % -

Accrued Expenses (Tables)

Accrued Expenses (Tables)	6 Months Ended
Accrued Expenses (Tables)	Jun. 30, 2023
Payables and Accruals [Abstract]
Schedule of Accrued Expenses	Accrued expenses consist of the following: Schedule of Accrued Expenses June 30, 2023 December 31, 2022 Compensation and related expenses $ 253,995 $ 295,935 Accounts Payable 188,144 76,727 Accrued Expenses $ 442,139 $ 372,662

Schedule of Earnings Per Share

Schedule of Earnings Per Share Anti-diluted (Details) - shares	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	3,478,899	3,825,035
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	712,500	945,837
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	1,135,000	1,235,000
Non Vested Restricted Stock Awards Units [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	1,631,399	1,644,198

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) - USD ($)		6 Months Ended
	Jun. 02, 2023	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Jan. 05, 2022
Property, Plant and Equipment [Line Items]
Cash and cash equivalents		$ 943,418		$ 2,146,783
Cash, FDIC insured amount		300,000		$ 1,700,000
Impairment losses		900,000	$ 12,200,000
Realized investment gains losses		$ 700,000	500,000
Income tax likelihood percentage description		Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities. Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement
Preferred Stock, Conversion Basis		The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board)
Payments of dividends		$ 0	635,000
Advertising and marketing expenses		$ 9,000	$ 65,000
Board of Directors [Member]
Property, Plant and Equipment [Line Items]
Dividend per share					$ 0.05
Series V Preferred Stock [Member]
Property, Plant and Equipment [Line Items]
Preferred Stock, Conversion Basis		The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board of Directors)
Preferred Stock [Member] \| Series V Preferred Stock [Member]
Property, Plant and Equipment [Line Items]
Stock Issued During Period, Shares, New Issues	14,542,803
Maximum [Member]
Property, Plant and Equipment [Line Items]
Cash, FDIC insured amount		$ 250,000
Property, plant and equipment, estimated useful lives		5 years
Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, estimated useful lives		3 years

Schedule of Fair Value of Asset

Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	$ 100,000	$ 100,000
Warrant liabilities	356,250	213,750
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments
Warrant liabilities
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments
Warrant liabilities
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	100,000	100,000
Warrant liabilities	$ 356,250	$ 213,750	$ 783,750	$ 1,852,500

Summary of Valuation Methodolog

Summary of Valuation Methodology and Significant Unobservable Inputs Warrant Liabilities (Details)	6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Risk-free rate of interest	4.10%	1.32%
Expected volatility	97.30%	103.72%
Expected life (in years)	4 years	5 years
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Risk-free rate of interest	4.49%		3.99%
Expected volatility	144.60%		152.80%
Expected life (in years)	2 years 8 months 4 days		3 years 2 months 4 days
Expected dividend yield

Schedule of Changes in Fair Val

Schedule of Changes in Fair Value and Other Adjustments of Warrants (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment, beginning balance			$ 100,000
Investment, ending balance	$ 100,000		100,000
Warrant liabilities, beginning balance			213,750
Fair value adjustment of warrant liabilities	(142,500)	$ (1,710,000)	142,500	$ (1,068,750)
Warrant liabilities, ending balance	356,250		356,250
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment, beginning balance			100,000
Purchases
Unrealized appreciation (depreciation)
Investment, ending balance	100,000		100,000
Warrant liabilities, beginning balance			213,750	1,852,500
Warrant liabilities classification
Fair value adjustment of warrant liabilities			142,500	(1,068,750)
Warrant liabilities, ending balance	$ 356,250	$ 783,750	$ 356,250	$ 783,750

Fair Value of Financial Asset_3

Fair Value of Financial Assets and Liabilities (Details Narrative) - USD ($)	Mar. 02, 2021	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments fair value		$ 100,000	$ 100,000
Securities Purchase Agreement [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Shares of common stock	950,000
Common stock warrants	712,500
Gross proceeds from private placement	$ 9,500,000
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments fair value		$ 100,000	$ 100,000

Schedule of Weighted-Average As

Schedule of Weighted-Average Assumptions Used to Estimate Fair Value (Details) - $ / shares	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Term (years)	4 years	5 years
Expected stock price volatility	97.30%	103.72%
Risk-free rate of interest	4.10%	1.32%
Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Exercise price	$ 3.81	$ 8.07
Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Exercise price	30.52	36.99
2021 Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Exercise price	$ 0.63
Term (years)	5 years
Expected stock price volatility	152.80%	(0.00%)
Risk-free rate of interest	3.99%	(0.00%)

Summary of Option Activity (Det

Summary of Option Activity (Details)	6 Months Ended
Summary of Option Activity (Details)	Jun. 30, 2023 USD ($) $ / shares shares
Equity [Abstract]
Number of shares outstanding, beginning balance \| shares	1,150,000
Weighted average exercise price, beginning balance	$ 2.15
Total Intrinsic value, beginning balance \| $
Weighted average remaining contractual life (in years), beginning balance	3 years 3 months 18 days
Number of shares outstanding, Employee options granted \| shares	20,000
Weighted average exercise price, employee options granted	$ 0.63
Total intrinsic value, employee options granted
Number of shares outstanding, Employee options forfeited \| shares	(35,000)
Weighted average exercise price, employee options forfeited	$ 1.02
Total intrinsic value, employee options forfeited	$ 11,100
Number of shares outstanding, ending balance \| shares	1,135,000
Weighted average exercise price, ending balance	$ 2.16
Total Intrinsic value, ending balance \| $
Weighted average remaining contractual life (in years), ending balance	2 years 9 months 18 days
Number of shares outstanding, options vested and exercisable \| shares	1,135,000
Weighted average exercise price, options vested and exercisable	$ 2.16
Total intrinsic value, options vested and exercisable \| $
Weighted average remaining contractual life (in years), options vested and exercisable	2 years 9 months 18 days

Schedule of Restricted Stock Un

Schedule of Restricted Stock Units (Details) - shares			6 Months Ended
Schedule of Restricted Stock Units (Details) - shares	Feb. 22, 2022	Jan. 02, 2022	Jun. 30, 2023
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares			1,521,296
Market Cap Vesting Thresholds $50 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares			380,324
Market Cap Vesting Thresholds $100 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares			380,324
Market Cap Vesting Thresholds $150 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares			380,324
Market Cap Vesting Thresholds $300 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares			380,324
Chief Executive Officer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
[custom:OfficerName]		Charles Allen
[custom:StockIssuedDuringPeriodRestrictedStockAwardGrantDate]		Jan. 02, 2022
Number of restricted stock units granted and vested, shares		694,444
Chief Executive Officer [Member] \| Market Cap Vesting Thresholds $50 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares		173,611
Chief Executive Officer [Member] \| Market Cap Vesting Thresholds $100 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares		173,611
Chief Executive Officer [Member] \| Market Cap Vesting Thresholds $150 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares		173,611
Chief Executive Officer [Member] \| Market Cap Vesting Thresholds $300 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares		173,611
Chief Operating Officer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
[custom:OfficerName]		Michal Handerhan
[custom:StockIssuedDuringPeriodRestrictedStockAwardGrantDate]		Jan. 02, 2022
Number of restricted stock units granted and vested, shares		444,444
Chief Operating Officer [Member] \| Market Cap Vesting Thresholds $50 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares		111,111
Chief Operating Officer [Member] \| Market Cap Vesting Thresholds $100 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares		111,111
Chief Operating Officer [Member] \| Market Cap Vesting Thresholds $150 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares		111,111
Chief Operating Officer [Member] \| Market Cap Vesting Thresholds $300 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares		111,111
Chief Financial Officer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
[custom:OfficerName]		Michael Prevoznik
[custom:StockIssuedDuringPeriodRestrictedStockAwardGrantDate]		Jan. 02, 2022
Number of restricted stock units granted and vested, shares		222,224
Chief Financial Officer [Member] \| Market Cap Vesting Thresholds $50 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares		55,556
Chief Financial Officer [Member] \| Market Cap Vesting Thresholds $100 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares		55,556
Chief Financial Officer [Member] \| Market Cap Vesting Thresholds $150 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares		55,556
Chief Financial Officer [Member] \| Market Cap Vesting Thresholds $300 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares		55,556
Chief Technology Officer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
[custom:OfficerName]	Manish Paranjape
[custom:StockIssuedDuringPeriodRestrictedStockAwardGrantDate]	Feb. 22, 2022
Number of restricted stock units granted and vested, shares	160,184
Chief Technology Officer [Member] \| Market Cap Vesting Thresholds $50 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares	40,046
Chief Technology Officer [Member] \| Market Cap Vesting Thresholds $100 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares	40,046
Chief Technology Officer [Member] \| Market Cap Vesting Thresholds $150 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares	40,046
Chief Technology Officer [Member] \| Market Cap Vesting Thresholds $300 Million [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock units granted and vested, shares	40,046

Summary of Restricted Stock (De

Summary of Restricted Stock (Details)	6 Months Ended
Summary of Restricted Stock (Details)	Jun. 30, 2023 $ / shares shares
Equity [Abstract]
Number of restricted stock units nonvested, beginning balance \| shares	1,590,552
Weighted average grant day fair value nonvested, beginning balance \| $ / shares	$ 3.34
Number of restricted stock units, granted \| shares	50,000
Weighted average grant day fair value, granted \| $ / shares	$ 0.63
Number of restricted stock units, vested \| shares	(9,153)
Weighted average grant day fair value, forfeited \| $ / shares	$ 4.37
Number of restricted stock units, forfeited \| shares
Weighted average grant day fair value, vested \| $ / shares
Number of restricted stock units nonvested, ending balance \| shares	1,631,399
Weighted average grant day fair value nonvested, ending balance \| $ / shares	$ 3.25

Schedule of Stock-based Compens

Schedule of Stock-based Compensation Expense (Details) - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation	$ 228,667	$ 508,182	$ 515,221	$ 1,895,914
Employee Bonus Stock Awards [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation				894,027
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation	(8,619)	12,812	(5,312)	82,446
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation	228,953	405,714	496,291	747,704
Non Employee Restricted Stock Awards [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation	$ 8,333	$ 89,656	$ 24,242	$ 171,737

Stockholders_ Equity (Details N

Stockholders’ Equity (Details Narrative) - USD ($)

1 Months Ended

6 Months Ended

Jun. 02, 2023

Jan. 19, 2023

Jan. 01, 2023

Dec. 09, 2022

Jan. 02, 2022

Sep. 14, 2021

Aug. 09, 2023

Jun. 30, 2023

Jun. 30, 2022

Jul. 12, 2023

Jul. 11, 2023

May 12, 2023

Dec. 31, 2022

Jun. 13, 2022

Class of Stock [Line Items]

Common stock, shares authorized

97,500,000

975,000,000

97,500,000

Liquidation preference

The
Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv)
has certain rights to dividends and distributions (at the discretion of the Board)

Preferred stock value

Weighted average exercise price

$ 0.63

Expected life (in years)

4 years

5 years

Restricted Stock Units (RSUs) One [Member]

Class of Stock [Line Items]

Market cap vesting thresholds, value

$ 50,000,000

$ 100,000,000

Restricted Stock Units (RSUs) Two [Member]

Class of Stock [Line Items]

Market cap vesting thresholds, value

100,000,000

150,000,000

Restricted Stock Units (RSUs) Three [Member]

Class of Stock [Line Items]

Market cap vesting thresholds, value

150,000,000

200,000,000

Restricted Stock Units (RSUs) Four [Member]

Class of Stock [Line Items]

Market cap vesting thresholds, value

$ 300,000,000

$ 400,000,000

Restricted Stock Units (RSUs) [Member]

Class of Stock [Line Items]

Expected life (in years)

5 years

Vesting period

5 years

2021 Equity Incentive Plan [Member]

Class of Stock [Line Items]

Number of additional shares authorized

7,000,000

Expected life (in years)

5 years

2021 Equity Incentive Plan [Member] | Subsequent Event [Member]

Class of Stock [Line Items]

Number of additional shares authorized

12,000,000

Series V Preferred Stock [Member]

Class of Stock [Line Items]

Liquidation preference

The Series V: (i) is non-convertible,
(ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and
distributions (at the discretion of the Board of Directors)

Preferred stock value

$ 2,559,533

Series V Preferred Stock [Member] | Preferred Stock [Member]

Class of Stock [Line Items]

Issuance of common stock, net of offering cost / At-the-market offering, shares

14,542,803

Preferred stock value

$ 2,600,000

Each Independent Director [Member]

Class of Stock [Line Items]

Stock option grant date fair value

$ 50,000

Each Independent Director [Member] | Four Equal Installments [Member]

Class of Stock [Line Items]

Stock option grant date fair value

$ 12,500

Independent Directors [Member]

Class of Stock [Line Items]

Share based payment issued

59,223

Non-executive Employees [Member] | Restricted Stock [Member]

Class of Stock [Line Items]

Stock option granted

25,000

Non-executive Employees [Member] | 2021 Equity Incentive Plan [Member]

Class of Stock [Line Items]

Stock option granted

20,000

Weighted average exercise price

$ 0.63

Chief Technology Officer [Member] | Restricted Stock Units (RSUs) [Member] | One-Year Anniversary [Member]

Class of Stock [Line Items]

Vesting rights, percentage

20%

Chief Technology Officer [Member] | Restricted Stock Units (RSUs) [Member] | Four-Year Anniversary [Member]

Class of Stock [Line Items]

Vesting rights, percentage

80%

At-the-Market Offering Agreement [Member]

Class of Stock [Line Items]

Sale of stock, number of shares issued in transaction

651,172

Gross proceeds from issuance of common stock

$ 965,000

Shares issued, price per share

$ 1.48

Proceeds from issuance initial public offering, net

$ 927,000

At-the-Market Offering Agreement [Member] | Subsequent Event [Member]

Class of Stock [Line Items]

Sale of stock, number of shares issued in transaction

151,882

Gross proceeds from issuance of common stock

$ 195,000

Shares issued, price per share

$ 1.28

At-the-Market Offering Agreement [Member] | H.C. Wainwright and Co., LLC [Member]

Class of Stock [Line Items]

Sale of stock, consideration received on transaction

$ 98,767,500

Percentage of gross proceeds of offerings

Schedule of Accrued Expenses (D

Schedule of Accrued Expenses (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Compensation and related expenses	$ 253,995	$ 295,935
Accounts Payable	188,144	76,727
Accrued Expenses	$ 442,139	$ 372,662

Accrued Expenses (Details Narra

Accrued Expenses (Details Narrative) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accrued bonuses current and non current	$ 254,000	$ 284,000

Employee Benefit Plans (Details

Employee Benefit Plans (Details Narrative) - USD ($)	6 Months Ended
Employee Benefit Plans (Details Narrative) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Retirement Benefits [Abstract]
Percentage of defined comtribution plan employee	100%
Defined comtribution plan employee	$ 95,000	$ 45,000

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	1 Months Ended	6 Months Ended
Subsequent Events (Details Narrative) - USD ($)	Aug. 09, 2023	Jun. 30, 2023	Jun. 30, 2022	Jul. 12, 2023	Jul. 11, 2023	Dec. 31, 2022
Subsequent Event [Line Items]
Proceeds from Issuance of Common Stock		$ 926,501	$ 10,604,441
Increase in number of shares		97,500,000		975,000,000	975,000,000	97,500,000
At-the-Market Offering Agreement [Member]
Subsequent Event [Line Items]
Sale of Stock, Number of Shares Issued in Transaction		651,172
[custom:GrossProceedsFromIssuanceOfCommonStock]		$ 965,000
Shares Issued, Price Per Share		$ 1.48
Subsequent Event [Member] \| Maximum [Member]
Subsequent Event [Line Items]
Increase in number of shares					975,000,000
Subsequent Event [Member] \| At-the-Market Offering Agreement [Member]
Subsequent Event [Line Items]
Sale of Stock, Number of Shares Issued in Transaction	151,882
[custom:GrossProceedsFromIssuanceOfCommonStock]	$ 195,000
Shares Issued, Price Per Share	$ 1.28
Proceeds from Issuance of Common Stock	$ 187,000